Beta Bionics (BBNX) EBIT Margin (2024 - 2025)
Beta Bionics' EBIT Margin history spans 2 years, with the latest figure at 50.2% for Q4 2025.
- For Q4 2025, EBIT Margin rose 1358.0% year-over-year to 50.2%; the TTM value through Dec 2025 reached 71.5%, down 202.0%, while the annual FY2025 figure was 71.5%, 202.0% down from the prior year.
- EBIT Margin for Q4 2025 was 50.2% at Beta Bionics, up from 62.54% in the prior quarter.
- Across five years, EBIT Margin topped out at 50.2% in Q4 2025 and bottomed at 105.69% in Q1 2025.